Filgrastim recalls

The FDA has published 2 recalls involving Filgrastim since 2025. The latest was reported on 26 Mar 2025. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2025

Last 12 months0reported

Class I00% of total

Ongoing2latest 26 Mar 2025

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 2 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why filgrastim is recalled

Potency & Assay2100%

Companies

Amgen2100%

By year

20252100%

Ongoing filgrastim recalls

2 active

Reported	Class	Recall	Company	Reason	Where
26 Mar 2025Drug	CLASS II	Neupogen (filgrastim) For Injection, 480 mcg recalled by AmgenNeupogen	Amgen	Potency & Assay	Nationwide
26 Mar 2025Drug	CLASS II	Neupogen (filgrastim) For Injection, 300mcg/ Single Dose Vials recalledNeupogen	Amgen	Potency & Assay	Nationwide

All filgrastim recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
26 Mar 2025Drug	CLASS II	Neupogen (filgrastim) For Injection, 480 mcg recalled by AmgenNeupogen	Amgen	Potency & Assay	Nationwide
26 Mar 2025Drug	CLASS II	Neupogen (filgrastim) For Injection, 300mcg/ Single Dose Vials recalledNeupogen	Amgen	Potency & Assay	Nationwide

Should you stop taking Filgrastim?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.